Correlation Between GlaxoSmithKline PLC and Avantis Emerging
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Avantis Emerging at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Avantis Emerging into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Avantis Emerging Markets, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Avantis Emerging and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Avantis Emerging. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Avantis Emerging.
Diversification Opportunities for GlaxoSmithKline PLC and Avantis Emerging
-0.13 | Correlation Coefficient |
Good diversification
The 3 months correlation between GlaxoSmithKline and Avantis is -0.13. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Avantis Emerging Markets in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Avantis Emerging Markets and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Avantis Emerging. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Avantis Emerging Markets has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Avantis Emerging go up and down completely randomly.
Pair Corralation between GlaxoSmithKline PLC and Avantis Emerging
Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to under-perform the Avantis Emerging. In addition to that, GlaxoSmithKline PLC is 1.48 times more volatile than Avantis Emerging Markets. It trades about -0.23 of its total potential returns per unit of risk. Avantis Emerging Markets is currently generating about -0.15 per unit of volatility. If you would invest 1,245 in Avantis Emerging Markets on August 31, 2024 and sell it today you would lose (36.00) from holding Avantis Emerging Markets or give up 2.89% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
GlaxoSmithKline PLC ADR vs. Avantis Emerging Markets
Performance |
| Timeline |
| GlaxoSmithKline PLC ADR |
| Avantis Emerging Markets |
GlaxoSmithKline PLC and Avantis Emerging Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with GlaxoSmithKline PLC and Avantis Emerging
The main advantage of trading using opposite GlaxoSmithKline PLC and Avantis Emerging positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Avantis Emerging can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avantis Emerging will offset losses from the drop in Avantis Emerging's long position.| GlaxoSmithKline PLC vs. Novartis AG ADR | GlaxoSmithKline PLC vs. AstraZeneca PLC ADR | GlaxoSmithKline PLC vs. Roche Holding Ltd | GlaxoSmithKline PLC vs. Bristol Myers Squibb |
| Avantis Emerging vs. Goldman Sachs Government | Avantis Emerging vs. Us Government Plus | Avantis Emerging vs. Franklin Adjustable Government | Avantis Emerging vs. Short Term Government Fund |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |